ZA931099B - Heterocyclic compounds their use and preparation - Google Patents

Heterocyclic compounds their use and preparation

Info

Publication number
ZA931099B
ZA931099B ZA931099A ZA931099A ZA931099B ZA 931099 B ZA931099 B ZA 931099B ZA 931099 A ZA931099 A ZA 931099A ZA 931099 A ZA931099 A ZA 931099A ZA 931099 B ZA931099 B ZA 931099B
Authority
ZA
South Africa
Prior art keywords
preparation
heterocyclic compounds
compounds
benzazepines
tetrahydro
Prior art date
Application number
ZA931099A
Other languages
English (en)
Inventor
Christian Foged
Rolf Hohlweg
Erik Bardrum Nielsen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of ZA931099B publication Critical patent/ZA931099B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
ZA931099A 1992-02-24 1993-02-17 Heterocyclic compounds their use and preparation ZA931099B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK92233A DK23392D0 (da) 1992-02-24 1992-02-24 Heterocykliske forbindelser, deres anvendelse og fremstilling

Publications (1)

Publication Number Publication Date
ZA931099B true ZA931099B (en) 1994-08-17

Family

ID=8091236

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA931099A ZA931099B (en) 1992-02-24 1993-02-17 Heterocyclic compounds their use and preparation

Country Status (23)

Country Link
EP (1) EP0628039B1 (xx)
JP (1) JPH07504172A (xx)
KR (1) KR100255739B1 (xx)
AT (1) ATE152450T1 (xx)
AU (1) AU667878B2 (xx)
BG (1) BG62208B1 (xx)
CA (1) CA2130678C (xx)
CZ (1) CZ288626B6 (xx)
DE (1) DE69310353T2 (xx)
DK (2) DK23392D0 (xx)
ES (1) ES2102019T3 (xx)
FI (1) FI113770B (xx)
GR (1) GR3023896T3 (xx)
HU (1) HU221314B1 (xx)
IL (1) IL104657A (xx)
NO (1) NO310193B1 (xx)
NZ (1) NZ249465A (xx)
RO (1) RO116088B1 (xx)
RU (1) RU2114839C1 (xx)
SK (1) SK281390B6 (xx)
UA (1) UA34451C2 (xx)
WO (1) WO1993017012A1 (xx)
ZA (1) ZA931099B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0750616T3 (da) * 1994-03-16 2001-07-23 Cenes Ltd Syreadditionssalte af 2,3,4,5-tetrahydro-1H-3-benzazapinforbindelser
AU700596B2 (en) * 1995-09-15 1999-01-07 Cenes Limited Acid addition salts of 2,3,4,5-tetrahydro-1H-3-benzazepine compounds
GB0130576D0 (en) * 2001-12-20 2002-02-06 Cenes Ltd Dopamine D1 receptor agonist pro-drug compounds & derivatives
DK2912019T3 (da) 2012-10-25 2021-05-25 Tetra Discovery Partners Llc Heteroarylhæmmere af pde4
US20150086480A1 (en) * 2013-09-26 2015-03-26 Tetra Discovery Partners, LLC Heteroaryl inhibitors of pde4

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK180485D0 (da) * 1985-04-22 1985-04-23 Novo Industri As Nitrogenholdige forbindelser
DK325188D0 (da) * 1988-06-15 1988-06-15 Novo Industri As Hidtil ukendte benzazepinderivater
DK67489D0 (da) * 1989-02-14 1989-02-14 Novo Industri As Nye benzazepinderivater

Also Published As

Publication number Publication date
IL104657A0 (en) 1993-06-10
ES2102019T3 (es) 1997-07-16
BG62208B1 (bg) 1999-05-31
DE69310353D1 (de) 1997-06-05
HUT71127A (en) 1995-11-28
FI943875A (fi) 1994-08-23
ATE152450T1 (de) 1997-05-15
NO943123L (no) 1994-08-24
AU3626593A (en) 1993-09-13
SK281390B6 (sk) 2001-03-12
DK0628039T3 (da) 1997-12-08
KR950700286A (ko) 1995-01-16
UA34451C2 (uk) 2001-03-15
DE69310353T2 (de) 1997-10-02
IL104657A (en) 1999-11-30
RO116088B1 (ro) 2000-10-30
RU94040719A (ru) 1996-07-10
DK23392D0 (da) 1992-02-24
NO943123D0 (no) 1994-08-24
CA2130678A1 (en) 1993-08-25
GR3023896T3 (en) 1997-09-30
RU2114839C1 (ru) 1998-07-10
KR100255739B1 (ko) 2000-05-01
EP0628039B1 (en) 1997-05-02
WO1993017012A1 (en) 1993-09-02
EP0628039A1 (en) 1994-12-14
HU9402434D0 (en) 1994-10-28
CA2130678C (en) 2004-04-20
FI943875A0 (fi) 1994-08-23
JPH07504172A (ja) 1995-05-11
NZ249465A (en) 1996-02-27
HU221314B1 (en) 2002-09-28
SK100094A3 (en) 1995-04-12
AU667878B2 (en) 1996-04-18
BG98993A (bg) 1995-05-31
CZ198894A3 (en) 1995-10-18
CZ288626B6 (cs) 2001-08-15
FI113770B (fi) 2004-06-15
NO310193B1 (no) 2001-06-05

Similar Documents

Publication Publication Date Title
KR100246065B1 (en) Substituted 3-aminoquinuclidines
IL119461A (en) 4,7-disubstituted -7H-pyrrolo ¬2, 3-d¾pyrimidines
MX9203018A (es) Fluoroalcoxibencilamino-derivados de heterociclos nitrogenados.
ES2078440T3 (es) Compuestos farmaceuticos.
IL110204A0 (en) Novel indolene derivatives, processes for their preparation and their use for the treatment of cns disorders
ATE206708T1 (de) Benzimidazolonderivate mit zentraler dopaminerger aktivität
ATE53377T1 (de) 1-substituierte tetralinderivate, ihre herstellung und verwendung.
ZA931099B (en) Heterocyclic compounds their use and preparation
DE3268605D1 (en) 3,7a-diazacyclohepta(j,k)fluorene derivatives, their preparation and therapeutical use
IT1264978B1 (it) Piridotiazine e piridotiazepine ad attivita' antiasmatica